Number of positive nodes - Current relevance in determining prognosis of oral cavity cancer after the recent AJCC staging update.


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
03 2019
Historique:
received: 28 07 2018
revised: 20 12 2018
accepted: 05 01 2019
entrez: 9 3 2019
pubmed: 9 3 2019
medline: 9 4 2020
Statut: ppublish

Résumé

Lymph node involvement and the number of positive nodes is a significant prognosticator in oral cavity cancers and current staging system does not incorporate it as an integral part. This was a retrospective study of oral cavity cancer patients who were operated during the time period of 2009-2017. The data was collected and analysed to assess the impact of increase in the number of positive nodes on survival and its comparison of survival statistics to current AJCC staging. A total of 1431 patients were included in this study and 32.5% of these patients had a node positive disease. Nodal positivity was a significant prognosticator on multivariate analysis. Number of positive nodes was modelled with restricted cubic spline function and it showed progressive worsening of survival functions with increase in number. On Kaplan Meier analysis there was a better separation of curves when number of positive nodes was used and Akaike information criterion (AIC) showed that it was a better prognosticator than existing AJCC staging. Number of positive nodes is a significant prognosticator of prognosis and hence should be considered in the AJCC staging system.

Identifiants

pubmed: 30846166
pii: S1368-8375(19)30001-6
doi: 10.1016/j.oraloncology.2019.01.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-5

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Suhas Kodasoge Rajappa (SK)

Department of Surgical Oncology - Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India. Electronic address: suhas9490@gmail.com.

Udip Maheshwari (U)

Department of Medical Oncology - Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India.

Jiten Jaipuria (J)

Department of Uro Oncology - Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India.

Anupam Kumar Singh (AK)

Department of Medicine - Santhosh Medical College, Ghaziabad, India.

Sumit Goyal (S)

Department of Medical Oncology - Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India.

Ullas Batra (U)

Department of Medical Oncology - Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India.

Rajeev Kumar (R)

Department of Surgical Oncology - Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India.

Ajay Kumar Dewan (AK)

Department of Surgical Oncology - Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH